Director, PRESIDENT AND CEO · Vera Therapeutics, Inc. · Class A Common Stock
Side
SELL
Value
$41K
Shares
900
Price
$45.51
Executed
Apr 14, 2026
Disclosed
Apr 15, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 14 executedApr 15, 2026 disclosed
VERA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Fordyce Marshall filed this Form 4 reporting a open-market sale of VERA on Apr 14, 2026. It became public on Apr 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, PRESIDENT AND CEO
Fordyce Marshallcik:0001859453
Issuer
Vera Therapeutics, Inc.cik:0001831828
Revision history · 0
No field has changed since this record was first ingested.
